Your session is about to expire
← Back to Search
AZD1390 + Radiation Therapy for Brain Cancer
Study Summary
This trial will test the safety and effectiveness of a new drug, AZD1390, for treating brain tumors.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My cancer outside the brain is under control for treatment in Arm B.I haven't had lung radiation in the last 8 weeks.I don't have serious side effects from previous treatments, except for hair loss.I have not had a heart attack or severe heart issues in the last 6 months.I do not have severe lung infections.I finished my first round of radiation 6 months ago for Arm A.I have had lung conditions that needed steroid treatment.I will undergo a test for IDH1 mutation on my tumor before joining the study.I haven't taken checkpoint inhibitors in the last 28 days or any other drugs in the last 7 days.I haven't taken lung-damaging drugs like busulfan or bleomycin in the last year.I am willing to take seizure prevention medication during the study.My cancer's MGMT promoter status has been tested.I am willing to take seizure prevention medication while on the study drug for Arm A.I have a confirmed solid tumor cancer and brain lesions shown by an MRI.I cannot have precise radiation therapy for my brain tumor.I have not had seizures caused by brain metastases or LMD.My seizures caused by a tumor are under control with stable medication.I have Type I, Type II, or steroid-induced diabetes.I have a confirmed diagnosis of GBM for treatment Arm A.I can provide a tissue sample from my cancer.I have a history of epilepsy or seizures not caused by my tumor.My GBM diagnosis is confirmed and my MGMT gene is unmethylated.I haven't taken any chemotherapy or new drugs in the last 28 days, nor CCNU or BCNU in the last 6 weeks.I am able to care for myself but may not be able to do active work.I can continue hormonal therapies if I am in Arm B of the study.I have a muscle disorder or my muscle enzyme levels are high.I have had a severe brain injury or stroke.I don't have uncontrolled seizures or take more than 2 seizure medications for my brain tumor.My condition has worsened or returned, as confirmed by scans.I haven't taken strong CYP3A4 inhibitors or inducers in the last 2 weeks.I do not have any severe illnesses like bad lung disease.I am currently on systemic steroid treatment for Arm A.I am currently taking medication that can cause seizures.
- Group 1: AZD1390 + Radiation Therapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does AZD1390 pose any risk to individuals who consume it?
"Based on the limited clinical evidence supporting AZD1390's safety and efficacy, our team has assigned it a score of 1."
To whom is eligibility for this research project extended?
"This clinical trial seeks to recruit 120 individuals aged 18-130 years old who have been diagnosed with leptomeningeal disease. Furthermore, they must be able to attain a Karnofsky Performance Score of 60 or higher and possess histological evidence of GBM solid tumor malignancy which can be seen via Magnetic Resonance Imaging (MRI). Participants cannot receive Stereotactic Radiosurgery treatment for their brain tumors if accepted into this trial.Note that Arm B has now closed recruitment."
What is the breadth of institutions currently undergoing this trial?
"Currently, the 4 sites recruiting for this medical trial are located in Pittsburgh, New york City, and Richmond. Additionally, there are other centres participating in recruitment efforts. It is suggested that interested patients select a nearby clinic to minimize their travel commitments if they decide to join the study."
Is this research program still open to participants?
"According to information sourced from clinicaltrials.gov, this medical trial is still recruiting participants. It was first launched on April 2nd 2018 and the most recent update occurred November 3rd 2022."
Are senior citizens qualified to partake in this trial?
"This research project is open to any individual over the age of majority and younger than 130 years old."
What are the main objectives of this trial's research?
"The primary aim of this medical research is to assess the occurrence of adverse and serious events over an assigned duration (6 weeks for Arm A, 3 weeks for Arm B, and 10 weeks for Arm C). Supplementary objectives include ascertaining patients' response rate according to RECIST 1.1 criteria in now-closed arm B, determining response rate through RANO-BM criteria also exclusive to closed arm B, and measuring AZD1390's food effect on participants from open arm A with blood samples collected across multiple time points as a basis for area under curve analysis."
How many individuals are being chosen to take part in this clinical study?
"Affirmative. According to clinicaltrials.gov, the research trial is still gathering candidates, having been first posted on April 2nd 2018 and most recently updated on November 3rd 2022. The project aims to enrol 120 individuals from 4 different locations."
Share this study with friends
Copy Link
Messenger